Summary Of: Dapagliflozin

Encyclodia Page On: Dapagliflozin

These Are Links To Other Documents

| IUPAC | CAS number | ATC code | PubChem | Formula | C | H | Cl | O | Mol. mass | SMILES | Synonyms | Bioavailability | Metabolism | Half life | Excretion | Pregnancy cat. | Legal status | Routes | rINN | USAN | Bristol-Myers Squibb | AstraZeneca | citation needed | diabetes | sodium-glucose transport proteins | reabsorption | IC50 | | pharmacology | stub | v | d | Oral antidiabetic drugs | Insulin analogs | A10 | Insulin | Sensitizers | Biguanides | Metformin | Buformin | Phenformin | TZDs | PPAR | Pioglitazone | Rivoglitazone | Rosiglitazone | Troglitazone | Dual PPAR agonists | Aleglitazar | Muraglitazar | Tesaglitazar | Secretagogues | Sulfonylureas | 1st generation | Carbutamide | Chlorpropamide | Gliclazide | Tolbutamide | Tolazamide | 2nd generation | Glipizide | Glibenclamide (Glyburide) | Gliquidone | Glyclopyramide | 3rd generation | Glimepiride | Meglitinides | Nateglinide | Repaglinide | Mitiglinide | GLP-1 | Exenatide | Liraglutide | Albiglutide | DPP-4 inhibitors | Alogliptin | Linagliptin | Saxagliptin | Sitagliptin | Vildagliptin | Analogs | Insulin lispro | Insulin aspart | Insulin glulisine | Insulin glargine | Insulin detemir | Inhalable insulin (Exubera) | Alpha-glucosidase inhibitors | Acarbose | Miglitol | Voglibose | Amylin | Pramlintide | SGLT2 | Remogliflozin | Sergliflozin | clinical trials | Withdrawn | Development | Categories | Pharmacology stubs | Glycosides | Anti-diabetic drugs | Bristol-Myers Squibb | All articles with unsourced statements | Articles with unsourced statements since October 2008 |